1. Home
  2. ATAI vs SGC Comparison

ATAI vs SGC Comparison

Compare ATAI & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • SGC
  • Stock Information
  • Founded
  • ATAI 2018
  • SGC 1920
  • Country
  • ATAI Germany
  • SGC United States
  • Employees
  • ATAI 83
  • SGC N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • SGC Apparel
  • Sector
  • ATAI Health Care
  • SGC Consumer Discretionary
  • Exchange
  • ATAI Nasdaq
  • SGC Nasdaq
  • Market Cap
  • ATAI 271.6M
  • SGC 281.4M
  • IPO Year
  • ATAI 2021
  • SGC N/A
  • Fundamental
  • Price
  • ATAI $1.46
  • SGC $11.12
  • Analyst Decision
  • ATAI Strong Buy
  • SGC Strong Buy
  • Analyst Count
  • ATAI 4
  • SGC 2
  • Target Price
  • ATAI $9.00
  • SGC $19.00
  • AVG Volume (30 Days)
  • ATAI 2.6M
  • SGC 53.3K
  • Earning Date
  • ATAI 03-17-2025
  • SGC 03-11-2025
  • Dividend Yield
  • ATAI N/A
  • SGC 5.04%
  • EPS Growth
  • ATAI N/A
  • SGC 35.19
  • EPS
  • ATAI N/A
  • SGC 0.73
  • Revenue
  • ATAI $331,000.00
  • SGC $565,676,000.00
  • Revenue This Year
  • ATAI $80.07
  • SGC $5.04
  • Revenue Next Year
  • ATAI N/A
  • SGC $5.54
  • P/E Ratio
  • ATAI N/A
  • SGC $15.99
  • Revenue Growth
  • ATAI N/A
  • SGC 4.12
  • 52 Week Low
  • ATAI $1.03
  • SGC $10.90
  • 52 Week High
  • ATAI $2.85
  • SGC $21.80
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 41.01
  • SGC 23.58
  • Support Level
  • ATAI $1.37
  • SGC $10.90
  • Resistance Level
  • ATAI $1.52
  • SGC $11.76
  • Average True Range (ATR)
  • ATAI 0.14
  • SGC 0.58
  • MACD
  • ATAI -0.03
  • SGC -0.28
  • Stochastic Oscillator
  • ATAI 26.13
  • SGC 5.53

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.

Share on Social Networks: